Research Article

Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment

Table 1

Composition of the prepared solid lipid nanoparticle formulations.

Formulation codeCIP (mg)LipidTween 80 (mg)Sodium deoxycholate (mg)
TypeMelting point (mg)

CIPIMW50IMW~614504522.5
CIPSTE50STE704504522.5
CIPSOF50SOF55–604504522.5
CIPDYN50DYN70–7445045

CIPIMW Ciprofloxacin solid lipid nanoparticles containing Imwitor.
CIPSTE Ciprofloxacin solid lipid nanoparticles containing Stearic acid.
CIPSOFT Ciprofloxacin solid lipid nanoparticles containing Softisan.
CIPDYN Ciprofloxacin solid lipid nanoparticles containing Dynasan.
Torchilin. Handbook of Nanomedical Research: Fundamentals, Applications and Recent Developments, Materials for Nanomedicine,Vol. 3.